← All organizations

Istituto Oncologico Veneto IRCCS

Academic/HospitalWebsite ↗

Also known as: Istituto Oncologico Veneto IOV IRCCS | Istituto Oncologico Veneto IRCCS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2025

Timeline

2000s

Jan 1, 2005
Istituto Oncologico Veneto IRCCS— Founded

Drugs by trial phase (27 distinct, 16 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (18 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Silibinin

Indications

Studied for

Recent trials (23)

NCT06964815Lead sponsorN/AOct 31, 2025
NCT06275919Lead sponsorPhase 2Sep 23, 2024
NCT06275919OfficialPhase 2Sep 23, 2024
NCT06155279Lead sponsorPhase 2Jun 30, 2024
NCT06155279OfficialPhase 2Jun 30, 2024
NCT06033092CollaboratorPhase 2Sep 1, 2023
NCT06095375Lead sponsorPhase 1Jul 4, 2022
NCT04259944Study chairPhase 2Mar 15, 2020
NCT04224441CollaboratorPhase 2Dec 15, 2019
NCT04182516Overall official - principal investigatorPhase 1Nov 25, 2019
NCT04656262Lead sponsorPhase 3Sep 10, 2018
NCT04659551Lead sponsorPhase 2Oct 5, 2017
NCT02926196Reponsible party - principal investigatorPhase 3Jun 1, 2016
NCT02926196Lead sponsorPhase 3Jun 1, 2016
NCT02926222Lead sponsorPhase 2Nov 1, 2015

Details

Founded: Padova, IT Jan 1, 2005
Last known activity: Oct 31, 2025